192 related articles for article (PubMed ID: 11330843)
1. Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats.
Wang J; Yuen VG; McNeill JH
Mol Cell Biochem; 2001 Feb; 218(1-2):93-6. PubMed ID: 11330843
[TBL] [Abstract][Full Text] [Related]
2. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
3. Effect of vanadium on insulin sensitivity and appetite.
Wang J; Yuen VG; McNeill JH
Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
[TBL] [Abstract][Full Text] [Related]
4. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.
Janssen SW; Martens GJ; Sweep CG; Ross HA; Hermus AR
Horm Metab Res; 1999 Nov; 31(11):610-5. PubMed ID: 10598829
[TBL] [Abstract][Full Text] [Related]
5. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats.
Yuen VG; Bhanot S; Battell ML; Orvig C; McNeill JH
Can J Physiol Pharmacol; 2003 Nov; 81(11):1049-55. PubMed ID: 14719040
[TBL] [Abstract][Full Text] [Related]
6. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
[TBL] [Abstract][Full Text] [Related]
8. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats.
Yuen VG; Pederson RA; Dai S; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1996 Sep; 74(9):1001-9. PubMed ID: 8960391
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
[TBL] [Abstract][Full Text] [Related]
10. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
11. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
12. Melatonin administration in diabetes: regulation of plasma Cr, V, and Mg in young male Zucker diabetic fatty rats.
Navarro-Alarcon M; Ruiz-Ojeda FJ; Blanca-Herrera RM; Kaki A; Adem A; Agil A
Food Funct; 2014 Mar; 5(3):512-6. PubMed ID: 24441643
[TBL] [Abstract][Full Text] [Related]
13. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
14. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
16. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
18. Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity.
Semiz S; McNeill JH
Mol Cell Biochem; 2002 Jul; 236(1-2):123-31. PubMed ID: 12190110
[TBL] [Abstract][Full Text] [Related]
19. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.
Janssen SW; Martens GJ; Sweep CG; Span PN; Verhofstad AA; Hermus AR
J Endocrinol Invest; 2003 Jun; 26(6):508-15. PubMed ID: 12952363
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats.
Jöhren O; Dendorfer A; Dominiak P; Raasch W
Brain Res; 2007 Dec; 1184():160-7. PubMed ID: 17945204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
